Related Experiment Videos
[Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics]
Abstract:
Ms M is a young female patient (born 1968) with paranoid schizophrenia. The first acute psychotic episode, which involved marked delirium, was treated with an atypical antipsychotic agent. During the next year, renewed hospitalisation and treatment with two other antipsychotics resulted only in partial improvement, and troublesome adverse effects were noted. Amelioration of all symptoms, both psychotic and debilitating, was finally obtained through prescription of a third atypical antipsychotic with which the patient was highly satisfied. We examine the value of first-line treatment of schizophrenia with atypical antipsychotics as of the first acute episodes of acute delirium in the light of current data in the literature.
Insights
This case study highlights the effectiveness of a third atypical antipsychotic in managing paranoid schizophrenia symptoms, including delirium. It underscores the importance of individualized treatment for psychotic disorders.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Schizophrenia is a complex mental disorder characterized by psychotic episodes.
- Atypical antipsychotics are commonly used in treating schizophrenia.
- Delirium can be a feature of acute psychotic episodes.
Observation:
- A patient with paranoid schizophrenia experienced a first acute psychotic episode with delirium.
- Initial treatment with an atypical antipsychotic provided only partial improvement with adverse effects.
- Subsequent treatments with two other antipsychotics also yielded limited success.
Findings:
- A third atypical antipsychotic led to complete amelioration of both psychotic and debilitating symptoms.
- The patient reported high satisfaction with the third atypical antipsychotic.
- This case suggests a potential benefit of sequential atypical antipsychotic trials.
Implications:
- The findings emphasize the need for personalized treatment strategies in schizophrenia.
- Exploring multiple atypical antipsychotics may be crucial for treatment-resistant cases.
- Further research is warranted on the efficacy of sequential atypical antipsychotic therapy.